PharmaShots Weekly Snapshot (November 18-22, 2019)
Published: Nov 22, 2019 | Tags: Lupin, Launches, Smart Device, Metered-Dose Inhalers, Support, Treatment, Respiratory Diseases, India
Published: Nov 21, 2019 | Tags: BioMarin, Reports, Submission, MAA, EMA, Valoctocogene Roxaparvovec, Hemophilia A
Published: Nov 21, 2019 | Tags: Medtronic, IN.PACT AV Drug-Coated Balloon, Receives, US, FDA, Approval, Arteriovenous Fistula Lesions
Published: Nov 21, 2019 | Tags: GSK, ViiV Healthcare, Signs, Exclusive, License Agreement, NIH, bNAb, HIV Infection
Published: Nov 21, 2019 | Tags: AstraZeneca, Calquence, acalabrutinib, Receives, US, FDA, Approval, Chronic Lymphocytic Leukemia, Project Orbis
??6. ? Knight Therapeutics Signs an Exclusive License Agreement with Onconova for Rigosertib in Canada
Published: Nov 21, 2019 | Tags: Knight Therapeutics, Signs, Exclusive, License Agreement, Onconova, Rigosertib, Canada
Published: Nov 21, 2019 | Tags: AbbVie, Exclusive, Option and License Agreement, HPN217, Expands, Existing Collaboration, Harpoon Therapeutics
Published: Nov 21, 2019 | Tags: Aerie, Rhokiinsa, netarsudil ophthalmic solution, 0.02%, EC, Approval, Open-Angle Glaucoma, Ocular Hypertension
9. Astellas Signs a License Agreement with Welldoc to Develop and Commercialize Digital Therapies
Published: Nov 20, 2019 | Tags: Astellas, Signs, License Agreement, Welldoc, Develop, Commercialize, Digital Therapies
Published: Nov 20, 2019 | Tags: Sanofi, Collaborates, Aetion, Leverage, Evidence Platform, Advancing, Regulatory Submissions
11. ?? Novartis Collaborates with Mila to Transform Therapies with Artificial Intelligence in Canada
Published: Nov 20, 2019 | Tags: Novartis, Collaborates, Mila, Transform Therapies, Artificial Intelligence, Canada
Published: Nov 20, 2019 | Tags: Alnylam, Givlaari, givosiran, Receives, US, FDA, Approval, First Therapy, Acute Hepatic Porphyria
Published: Nov 20, 2019 | Tags: AbbVie, Collaborates, Dragonfly Therapeutics, Develop, Therapies, Autoimmune, Oncology
Published: Nov 20, 2019 | Tags: BMS, Reports, Update, Opdivo, nivolumab, Yervoy, ipilimumab, P-III, CheckMate -915, Study, Patients, Resected High-Risk Melanoma, PD-L1 <1%
Published: Nov 20, 2019 | Tags: Merck, Keytruda, pembrolizumab, Receives, EC, Approval, 1L, Treatment, Metastatic, Unresectable, Recurrent, Head and Neck Squamous Cell Carcinoma
Published: Nov 19, 2019 | Tags: BioVentrix, Revivent TC Transcatheter Ventricular Enhancement System, Receives, FDA, Breakthrough Device Designation, Heart Failure
17. ??? Janssens Darzalex (daratumumab) Combination Regimen Receives ECs Approval for Transplant Ineligible Patients with Newly Diagnosed Multiple Myeloma
Published: Nov 19, 2019 | Tags: Janssen, Darzalex, daratumumab, Combination Regimen, Receives, EC, Approval, Transplant Ineligible Patients, Newly Diagnosed Multiple Myeloma
Published: Nov 19, 2019 | Tags: Myovant Sciences, Reports, Results, Relugolix, P-III, HERO Study, Men, Advanced Prostate Cancer
Published: Nov 20, 2019 | Tags: CRISPR Therapeutics, Vertex, Reports, Results, CTX001, Severe Hemoglobinopathies
20. Merck KGaA Collaborates with Personalis to Develop Novel Biomarkers for Cancer Therapies
Published: Nov 19, 2019 | Tags: Merck KGaA, Collaborates, Personalis, Develop, Novel Biomarkers, Cancer Therapies
21. Samsung Bioepis Reports FDAs Acceptance of BLA for SB8 (biosimilar, bevacizumab)
Published: Nov 19, 2019 | Tags: Samsung Bioepis, Reports, FDA, Acceptance, BLA, SB8, biosimilar, bevacizumab
Published: Nov 18, 2019 | Tags: Vertex, Collaborate, Molecular Templates, Discover, Develop, Conditioning Regimens, Enhancing, Hematopoietic Stem Cell Transplants
?23. ? Janssen Redefines Clinical Trial Design by Leveraging Wearable Technology
Published: Nov 19, 2019 | Tags: Janssen, Redefines, Clinical Trial Design, Leveraging, Wearable Technology
24. ? Santhera Reports Results of Idebenone in SYROS Study for Duchenne Muscular Dystrophy
Published: Nov 19, 2019 | Tags: Santhera, Reports, Results, Idebenone, SYROS, Study, Duchenne Muscular Dystrophy
25. ?? Alkermes to Acquire Rodin Therapeutics for $950M
Published: Nov 18, 2019 | Tags: Alkermes, Acquire, Rodin Therapeutics, $950M
26. Novartis Collaborates with Biofourmis To Offer Digital Therapeutics for Managing Heart Failures
Published: Nov 18, 2019 | Tags: Novartis, Collaborates, Biofourmis, Digital Therapeutics, Managing, Heart Failures
Published: Nov 18, 2019 | Tags: Merck, Bayer, Report, Results, Vericiguat, P-III, VICTORIA Study, Worsening Chronic Heart Failure
28. Aerie Pharmaceuticals to Acquire Avizorex Pharma to Expand its Footprint in Ophthalmology
Published: Nov 18, 2019 | Tags: Aerie Pharmaceuticals, Acquire, Avizorex Pharma, Expand, Footprint, Ophthalmology
Published: Nov 18, 2019 | Tags: Novo Nordisk, Collaborates, Dicerna, Discover, Develop, RNAi therapies, Liver-Related Cardio-Metabolic Diseases
Published: Nov 15, 2019 | Tags: Novartis, Adakveo, crizanlizumab, Receives, US, FDA, Approval, Reducing, Frequency, VOCs, Sickle Cell Disease
31. Pfizers Abrilada (biosimilar, adalimumab) Receives the US FDAs Approval for Rheumatoid Arthritis
Published: Nov 15, 2019 | Tags: Pfizer, Abrilada, biosimilar, adalimumab, Receives, US, FDA, Approval, Rheumatoid Arthritis
32. Roche to Acquire Promedior for $1.39B
Published: Nov 15, 2019 | Tags: Roche, Acquire, Promedior, $1.39B
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com